Abbott Laboratories (ABT) Operating Leases (2019 - 2021)

Abbott Laboratories' Operating Leases history runs 3 years deep, the most recent figure standing at $956.0 million for Q4 2021.

• In Q4 2021, Operating Leases rose 5.99% year-over-year to $956.0 million; the TTM figure through Dec 2021 stood at $956.0 million (up 5.99% YoY), while the FY2021 annual figure was $956.0 million, up 5.99% from the prior year.
• Operating Leases came in at $956.0 million for Q4 2021 at Abbott Laboratories, up from $902.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $956.0 million in Q4 2021 to a low of $755.0 million in Q4 2019.
• A 3-year average of $871.0 million and a median of $902.0 million in 2020 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases advanced 19.47% in 2020 and grew 5.99% in 2021, its largest moves.
• Abbott Laboratories' Operating Leases stood at $755.0 million in 2019, then grew by 19.47% to $902.0 million in 2020, then advanced by 5.99% to $956.0 million in 2021.
• According to Business Quant data, Operating Leases over the past three periods registered $956.0 million, $902.0 million, and $755.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.

Peer Comparison